Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.

A study by scientists from Rutgers University and Columbia University has found that adults with depression who started ...

In animal studies, boosting serotonin in the cells that line the gut reduced anxious and depressive-like behaviors without causing cognitive or gastrointestinal side effects. Most of us have ...

A popular antidepressant taken by millions has been ... More than 23 million people in America are prescribed duloxetine to treat depression and anxiety each year. The recall from Rising ...

In a statement, Neumora revealed that the KOASTAL-1 study missed its primary endpoint, with navacaprant failing to achieve a ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a major clinical trial.

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD ... Both drugs were given on top of standard antidepressants to patients wo had failed a least two earlier treatments.